Mal de Meleda: Diagnostic Work-up and Therapy with Low-dose Acitretin
DOI:
https://doi.org/10.2340/actadv.v102.995Keywords:
Hereditary palmoplantar keratoderma, low-dose retinoid therapy, , keratosis palmoplantaris transgrediens et progrediens,, Mal de MeledaAbstract
Abstract is missing (Short communication)
Downloads
References
Fatovic-Ferencic S, Holubar K. The portrait and paper of a forgotten hero - Luca Stulli (1772-1828) and the Mal de Meleda of yesteryear: a 175-year anniversary. J Invest Dermatol 2001; 116: 198-199.
https://doi.org/10.1046/j.1523-1747.2001.00225.x DOI: https://doi.org/10.1046/j.1523-1747.2001.00225.x
van de Kerkhof PC, van Dooren-Greebe RJ, Steijlen PM. Acitretin in the treatment of mal de Meleda. Br J Dermatol 1992; 127: 191-192.
https://doi.org/10.1111/j.1365-2133.1992.tb08060.x DOI: https://doi.org/10.1111/j.1365-2133.1992.tb08060.x
Jo JW, Jeong DS, Kim CY. Case of punctate palmoplantar keratoderma type I treated with combination of low-dose oral acitretin and topical salicylic acid and steroid. J Dermatol 2018; 45: 609-612.
https://doi.org/10.1111/1346-8138.14255 DOI: https://doi.org/10.1111/1346-8138.14255
Gruber R, Edlinger M, Kaspar RL, Hansen CD, Leachman S, Milstone LM et al.. An appraisal of oral retinoids in the treatment of pachyonychia congenita. J Am Acad Dermatol 2012; 66: e193-e199.
https://doi.org/10.1016/j.jaad.2011.02.003 DOI: https://doi.org/10.1016/j.jaad.2011.02.003
Guerra L, Castori M, Didona B, Castiglia D, Zambruno G. Hereditary palmoplantar keratodermas. Part I. Non-syndromic palmoplantar keratodermas: classification, clinical and genetic features. J Eur Acad Dermatol Venereol 2018; 32: 704-719.
https://doi.org/10.1111/jdv.14902 DOI: https://doi.org/10.1111/jdv.14902
Lestringant GG, Hadi SM, Qayed KI, Blayney BJ. Mal de Meleda: recessive transgressive palmoplantar keratoderma with three unusual facultative features. Dermatology 1992; 184: 78-82.
https://doi.org/10.1159/000247506 DOI: https://doi.org/10.1159/000247506
Mozzillo N, Nunziata CA, Caraco C, Fazioli F, Botti G, Melanoma Cooperative Group. Malignant melanoma developing in an area of hereditary palmoplantar keratoderma (Mal de Meleda). J Surg Oncol 2003; 84: 229-233.
https://doi.org/10.1002/jso.10317 DOI: https://doi.org/10.1002/jso.10317
Fischer J, Bouadjar B, Heilig R, Huber M, Lefèvre C, Jobard F et al. Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 2001; 10: 875-880.
https://doi.org/10.1093/hmg/10.8.875 DOI: https://doi.org/10.1093/hmg/10.8.875
Gruber R, Hennies HC, Romani N, Schmuth M. A novel homozygous missense mutation in SLURP1 causing Mal de Meleda with an atypical phenotype. Arch Dermatol 2011; 147: 748-750.
https://doi.org/10.1001/archdermatol.2011.138 DOI: https://doi.org/10.1001/archdermatol.2011.138
Arredondo J, Chernyavsky AI, Webber RJ, Grando SA. Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol 2005; 125: 1236-1241.
https://doi.org/10.1111/j.0022-202X.2005.23973.x DOI: https://doi.org/10.1111/j.0022-202X.2005.23973.x
Chernyavsky AI, Galitovskiy V, Shchepotin IB, Grando SA. Anti-inflammatory effects of the nicotinergic peptides SLURP-1 and SLURP-2 on human intestinal epithelial cells and immunocytes. Biomed Res Int 2014; 2014: 609086.
https://doi.org/10.1155/2014/609086 DOI: https://doi.org/10.1155/2014/609086
Kudo M, Ishiura N, Tamura-Nakano M, Shimizu T, Kamata M, Akasaka E et al.. Abnormal keratinization and cutaneous inflammation in Mal de Meleda. J Dermatol 2020; 47: 554-558.
https://doi.org/10.1111/1346-8138.15296 DOI: https://doi.org/10.1111/1346-8138.15296
Bodemer C, Steijlen P, Hautier JM, O'Toole EA. Treatment of hereditary palmoplantar keratoderma: a review by analysis of the literature. Br J Dermatol 2020; 184: 393-400.
https://doi.org/10.1111/bjd.19144 DOI: https://doi.org/10.1111/bjd.19144
Bergfeld WF, Derbes VJ, Elias PM, Frost P, Greer KE, Shupack JL. The treatment of keratosis palmaris et plantaris with isotretinoin: a multicenter study. J Am Acad Dermatol 1982; 6: 727-731.
https://doi.org/10.1016/S0190-9622(82)80053-4 DOI: https://doi.org/10.1016/S0190-9622(82)80053-4
Park HK, Kim EJ, Ko JY. Alitretinoin: treatment for refractory palmoplantar keratoderma. Br J Dermatol 2016; 174: 1143-1144.
https://doi.org/10.1111/bjd.14327 DOI: https://doi.org/10.1111/bjd.14327
Published
How to Cite
License
Copyright (c) 2022 Isabella Pospischil, Klaus Enzelsberger, Susanne Gross, Wolfram Hoetzenecker, Tobias W. Fischer
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
